UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018515
Receipt number R000021431
Scientific Title Evaluation of the therapeutic effect of edoxaban in VTE patients
Date of disclosure of the study information 2015/08/01
Last modified on 2019/02/03 20:00:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the therapeutic effect of edoxaban in VTE patients

Acronym

Evaluation of the therapeutic effect of edoxaban in VTE patients

Scientific Title

Evaluation of the therapeutic effect of edoxaban in VTE patients

Scientific Title:Acronym

Evaluation of the therapeutic effect of edoxaban in VTE patients

Region

Japan


Condition

Condition

venous thromboembolism

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

investigate or establish the safety and effectiveness of LIXIANAffor VTE patients

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

regression of the thombus after 3 months of treatment are evaluated using ultrasonography or CT

Key secondary outcomes

Anemia and influence to the kidney function before and after therapy are evaluated by blood test


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patient who participated in medical examination and treatment using edoxaban in our hospital

Key exclusion criteria

The person bleeding at present

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhiro Shimizu

Organization

Toho University Sakura Medical Center

Division name

Internal medicine cardiology division

Zip code


Address

564-1 Shimosizu Sakura Chibaken Japan

TEL

+81-43-462-8811

Email

k432@sakura.med.toho-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuhiro Shimizu

Organization

Toho University Sakura Medical Center

Division name

Internal medicinae cardiology division

Zip code


Address

564-1 Shimosizu Sakura Chibaken Japan

TEL

+81-43-462-8811

Homepage URL


Email

k432@sakura.med.toho-u.ac.jp


Sponsor or person

Institute

Toho University

Institute

Department

Personal name



Funding Source

Organization

TOHO University Sakura medical center cardiology division

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東邦大学医療センター佐倉病院(千葉県)


Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

A thrombus of VTE was
significantly reduced by 3 months theray using edoxaban.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2015 Year 07 Month 17 Day

Date of IRB


Anticipated trial start date

2015 Year 07 Month 17 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 08 Month 01 Day

Last modified on

2019 Year 02 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021431


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name